September 24, 2017
1 min read
Save

Allergan’s patent deal with Native American tribe tops cornea news

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Allergan’s announcement that it will transfer its patent for Restasis to a New York-based Native American tribe led the recent cornea-related news, with trial updates and drug commercialization deals also making headlines this month.

Here are five of the most recent cornea/external disease stories on Healio.com/OSN:

 

1. Allergan enters patent protection deal with Native American tribe, files suit against Imprimis

Allergan announced two recent moves to protect its intellectual property and prevent generic competition. Read more.

2. Aldeyra announces positive results from dry eye treatment trial

A phase 2a clinical trial of topical ocular ADX-102 in patients with dry eye disease showed significant improvements across several sign and symptom endpoints. Read more.

3. Nicox enters agreement with Eyevance for US commercialization of Zerviate

Eyevance will make a one-time upfront payment of $6 million to Nicox under the agreement, and Nicox is eligible to receive up to $42.5 million in future milestones. Read more.

4. Diabetes affects cell density after phacoemulsification

Individuals with diabetes undergoing cataract surgery experienced more endothelial cell loss than those without diabetes, according to a study. Read more.

5. Cambodia, Laos eliminate trachoma

Trachoma, the leading infectious cause of blindness worldwide, has been eliminated as a public health problem in Cambodia and the Lao People’s Democratic Republic, the WHO announced. Read more.